Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-10-29 01:30Core Insights - The stock of Steady Medical (300888) closed at 40.25 yuan on October 28, 2025, with a 4.6% increase and a trading volume of 169,900 shares, amounting to a total transaction value of 689 million yuan [1][2]. Financial Performance - For Q3 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% year-on-year [5]. - The company's Q3 single-quarter main revenue was 2.601 billion yuan, reflecting a 27.71% year-on-year increase, while the single-quarter net profit was 240 million yuan, up 42.11% year-on-year [5]. - The company’s gross profit margin stands at 48.32%, with a net profit margin of 9.81% [5]. Market Position - Steady Medical has a total market capitalization of 23.439 billion yuan, ranking 4th in the beauty and personal care industry [5]. - The company has a net asset value of 12.263 billion yuan, leading the industry rankings [5]. - The price-to-earnings ratio (P/E) is 24.02, significantly lower than the industry average of 42.38, indicating a potentially undervalued stock [5]. Capital Flow - On October 28, 2025, the net outflow of main funds was 16.2688 million yuan, accounting for 2.36% of the total transaction value, while retail investors saw a net inflow of 48.1221 million yuan, representing 6.98% of the total transaction value [1][2]. - The financing data indicates a net repayment of 16.5646 million yuan on the same day, with a financing balance of 306 million yuan [3]. Institutional Ratings - Over the past 90 days, 18 institutions have rated the stock, with 15 buy ratings and 3 hold ratings, and the average target price set at 55.11 yuan [6].